Novartis to exit Indian unit in $159 million deal

robot
Abstract generation in progress

Novartis to exit Indian unit in $159 million deal

The company’s logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz, Switzerland, January 29, 2020. REUTERS/Arnd Wiegmann · Reuters

Reuters

Fri, 20 February 2026 at 12:41 pm GMT+9 1 min read

In this article:

NOVN.SW

-0.71%

Feb 20 (Reuters) - Swiss drugmaker Novartis said on Friday ‌it would sell its ‌entire 70.68% stake in its listed ​Indian unit for 14.46 billion rupees ($159 million).

The stake will be acquired by a ‌consortium of ⁠WaveRise Investments, ChrysCapital and Two Infinity Partners.

The companies ⁠have also made an offer to purchase an ​additional 26% ​stake from ​Novartis India’s ‌public shareholders, under takeover regulations that mandate such an exercise on purchase of a shareholding of over 25%.

The consortium ‌will offer Novartis ​India’s public shareholders ​860.64 ​rupees per share, ‌an exchange filing showed, ​representing ​a 3.6% premium to its closing price on Thursday.

($1 = ​91.0290 ‌Indian rupees)

(Reporting by Nandan ​Mandayam in Bengaluru; Editing by ​Sonia Cheema)

Terms and Privacy Policy

Privacy dashboard

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin